Tiger Jade Capital
VC Fund
Central and Western, Hong Kong
Tiger Jade Capital is a VC fund in Central and Western focused on Biotechnology and Oncology. Tiger Jade Capital is the support and cornerstone investment of China's leading CRO Company TigerMed.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Tiger Jade Capital invests in
Stages Tiger Jade Capital invests in
Countries Tiger Jade Capital invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Oncology 1 (33%)
- Biopharma 1 (33%)
- Health Care 1 (33%)
- Life Science 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Venture - Series Unknown 1 (33%)
Country
- Hong Kong 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's headquarters are in Palo Alto, California. | $40M / Venture - Series Unknown / Jun 17, 2026 | |
|
|
Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages. | $15M / Series A / Sep 13, 2022 | |
|
|
Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages. | $15M / Series B / Sep 13, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Tiger Jade Capital invest in?
Tiger Jade Capital invests primarily in Biotechnology, Oncology and Biopharma startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Tiger Jade Capital last invest?
The most recent investment recorded for Tiger Jade Capital closed in Jun 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!